Geftifos 250mg Tablet 10s

Introduction to Geftifos 250mg Tablet 10s

Geftifos 250mg Tablet 10s is a medication primarily used to treat a specific type of lung cancer known as non-small cell lung cancer (NSCLC). It is particularly effective for patients with certain genetic mutations called EGFR mutations. This medicine is usually prescribed to patients who have not undergone chemotherapy before.

Composition of Geftifos 250mg Tablet 10s

The active ingredient in Geftifos 250mg Tablet is Gefitinib. This component works by targeting and blocking signals that promote cancer cell growth, specifically in cells with mutated EGFR receptors.

Uses of Geftifos 250mg Tablet 10s

• Treatment of locally advanced non-small cell lung cancer (NSCLC)
• Management of metastatic NSCLC with EGFR mutations
• Prescribed for patients who have not received prior chemotherapy

Side effects of Geftifos 250mg Tablet 10s

Common side effects:

• Diarrhea
• Skin rash
• Nausea
• Vomiting
• Loss of appetite

Serious side effects:

• Liver toxicity
• Lung inflammation
• Severe diarrhea leading to dehydration

Precautions of Geftifos 250mg Tablet 10s

Geftifos should not be used by individuals without EGFR mutations, pregnant or breastfeeding women, or those with severe liver or kidney disease. It is also contraindicated for patients with a history of interstitial lung disease or those allergic to Gefitinib or any of its ingredients.

How to Take Geftifos 250mg Tablet 10s

• Take one tablet orally once daily.
• Consume the tablet at the same time each day for consistency.
• Follow your doctor's instructions regarding dosage and duration.

Conclusion of Geftifos 250mg Tablet 10s

Geftifos 250mg Tablet 10s is a targeted therapy for certain types of lung cancer, offering hope to patients with specific genetic profiles. While it can be highly effective, it is important to be aware of potential side effects and take necessary precautions. Always consult with your healthcare provider for personalized advice and treatment plans.